Please read and agree to the terms and conditions of this site.
@cointelegraph.com 4 months ago
AstraZeneca partners with AI company to find cure for cancer
@theverge.com 1 year ago
Slay vampiric gods in Redfall’s new story trailer
@Purdue_RCHE 1 year ago
Petros Drineas: Prof./Assoc. Head of @PurdueCS and the #RCHE Assoc. Dir of Health #DataScience. His focus is on genetic variation to inform the risk of disease & characterize #healthconditions and improve medical interventions and therapeutics. #Purdue #Healthcare #Research https://t.co/uFQuFq57JB
@theverge.com 1 year ago
Woman receives 3D-printed ear made from her own cells
@tech.eu 1 year ago
More than a Sidekick! Iceland’s digital therapeutics player kicks in $55 million to boost chronic disease treatments
@slashgear.com 2 years ago
Human proteins enable researchers to deliver medication directly to the cells
@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@techcrunch.com 2 years ago
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com 3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com 4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com 4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com 4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com 4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com 4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com 4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@ENERGY 4 years ago
.@argonne becomes newest member of the Accelerating Therapeutics for Opportunities in Medicine, or #ATOM, in hopes of using #AI & #MachineLearning to revolutionize the current drug discovery process into a faster, more patient oriented model. ➡️ https://bit.ly/2oe8itL https://t.co/FYHejhI5pn
@xconomy.com 4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com 4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@techcrunch.com 4 years ago
Risks and rewards of digital therapeutics in treating mental disorders
@techcrunch.com 4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@geekwire.com 5 years ago
Seattle startup Rodeo Therapeutics raises more cash for regenerative medicine treatments
@xconomy.com 5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com 5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@techcrunch.com 5 years ago
Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
@xconomy.com 5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com 5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com 5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com 5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com 5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com 5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com 5 years ago
CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable
@xconomy.com 5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com 5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com 5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
@xconomy.com 5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@venturebeat.com 6 years ago
Relay Therapeutics Secures $63 Million in Series B Financing
@theverge.com 7 years ago
Shell shock: why is a startup charging parents $180 for $2 worth of peanut butter?
@venturebeat.com 8 years ago
Solace Therapeutics Completes Enrollment of the SUCCESS Clinical Trial for the Vesair® Bladder Control System for Stress Urinary Incontinence